Company Filing History:
Years Active: 2025
Title: Innovations of Lin Li in Starch-Based Carrier Materials
Introduction
Lin Li is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of material science, particularly in the development of starch-based carrier materials. His innovative work focuses on enhancing the bioavailability of active substances through targeted delivery systems.
Latest Patents
Lin Li holds a patent for a "Starch-based carrier material with M cell targeting performance and pH responsiveness, and preparation method therefor and use thereof." This patent describes a starch-based carrier material that exhibits a molecular weight ranging from 7.04×10 to 2.11×10 g/mol. The material features a degree of substitution of carboxymethyl groups between 0.04 to 0.28 and a grafting amount of targeting peptide GRGDS from 0.01% to 1.12%, calculated based on the content of nitrogen. The carrier material is designed to remain undissolved in the acidic environment of the stomach (pH=1.2) while slowly dissolving in the small intestine (pH=6.8). This pH responsiveness allows for efficient encapsulation of positively charged active substances, protecting them from degradation in the gastrointestinal tract. Additionally, the material targets M cells to enhance the transport efficiency of active substances, thereby improving their bioavailability.
Career Highlights
Lin Li is affiliated with the South China University of Technology, where he continues to advance his research in innovative materials. His work has garnered attention for its potential applications in drug delivery systems and other biomedical fields.
Collaborations
Lin Li collaborates with notable colleagues, including Xiaoxi Li and Yiping Zhang, who contribute to his research endeavors and help further the development of his innovative projects.
Conclusion
Lin Li's contributions to the field of starch-based carrier materials demonstrate his commitment to advancing material science and improving drug delivery systems. His innovative patent highlights the potential for enhanced bioavailability of active substances, showcasing the importance of targeted delivery in biomedical applications.